TalantaSARS-CoV-2HumansImmunoassayInfluenza B virusCOVID-19
Self-enhancing triplex lateral flow assay for simultaneous detection of influenza A, influenza B, and SARS-CoV-2.
Lingyan Kang, Tao Xu, Zhimeng Fan, Yiqi Li, Ye Tian
Published: 202610.1016/j.talanta.2025.129228
Abstract
Achieving multiplexed, equipment-free, and sensitivity-enhanced antigen detection within a true one-step lateral flow format remains a technical challenge. Lateral flow immunoassays (LFIAs) are widely used for point-of-care diagnostics, yet their sen…
Preview only. Read the full abstract at the source